Arete Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,501
| Closed | -$247K | – | 597 |
|
2023
Q4 | $247K | Buy |
+2,501
| New | +$247K | 0.02% | 600 |
|
2023
Q3 | – | Sell |
-3,139
| Closed | -$381K | – | 631 |
|
2023
Q2 | $381K | Buy |
3,139
+451
| +17% | +$54.7K | 0.03% | 425 |
|
2023
Q1 | $413K | Buy |
2,688
+843
| +46% | +$130K | 0.03% | 387 |
|
2022
Q4 | $331M | Buy |
1,845
+125
| +7% | +$22.5M | 0.03% | 430 |
|
2022
Q3 | $203K | Sell |
1,720
-50
| -3% | -$5.9K | 0.02% | 516 |
|
2022
Q2 | $253K | Buy |
+1,770
| New | +$253K | 0.03% | 372 |
|
2022
Q1 | – | Sell |
-1,824
| Closed | -$447K | – | 539 |
|
2021
Q4 | $447K | Sell |
1,824
-359
| -16% | -$88K | 0.04% | 304 |
|
2021
Q3 | $834K | Buy |
+2,183
| New | +$834K | 0.09% | 186 |
|